These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1747440)

  • 1. Draft guideline on detection of toxicity to reproduction for medicinal products.
    Bass R; Ulbrich B; Hildebrandt AG; Weissinger J; Doi O; Baeder C; Fumero S; Harada Y; Lehmann H; Manson J
    Adverse Drug React Toxicol Rev; 1991; 10(3):127-41. PubMed ID: 1747440
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposal for international guidelines for reproductive and developmental toxicity testing for pharmaceuticals.
    Lumley CE
    Adverse Drug React Toxicol Rev; 1991; 10(3):143-53. PubMed ID: 1747441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproductive toxicology guidelines: comparison and application.
    Beltrame D; Mazué G
    Ann Ist Super Sanita; 1993; 29(1):3-14. PubMed ID: 8129269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity.
    Ema M; Fukui Y; Aoyama H; Fujiwara M; Fuji J; Inouye M; Iwase T; Kihara T; Oi A; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
    Congenit Anom (Kyoto); 2007 Jun; 47(2):74-6. PubMed ID: 17504392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP-CERHR expert panel report on the reproductive and developmental toxicity of acrylamide.
    Manson J; Brabec MJ; Buelke-Sam J; Carlson GP; Chapin RE; Favor JB; Fischer LJ; Hattis D; Lees PS; Perreault-Darney S; Rutledge J; Smith TJ; Tice RR; Working P
    Birth Defects Res B Dev Reprod Toxicol; 2005 Feb; 74(1):17-113. PubMed ID: 15729727
    [No Abstract]   [Full Text] [Related]  

  • 6. National Toxicology Program Center for the Evaluation of Risks to Human Reproduction: guidelines for CERHR expert panel members.
    Shelby MD;
    Birth Defects Res B Dev Reprod Toxicol; 2005 Feb; 74(1):9-16. PubMed ID: 15729730
    [No Abstract]   [Full Text] [Related]  

  • 7. Reproduction and teratology guidelines: review of deliberations by the National Toxicology Advisory Committee's reproduction panel.
    Collins TF
    J Environ Pathol Toxicol; 1978; 2(1):141-7. PubMed ID: 722218
    [No Abstract]   [Full Text] [Related]  

  • 8. Do natural compounds need specific drug development?
    Simon P; Verry M
    Prog Clin Biol Res; 1988; 280():407-21. PubMed ID: 3051029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental design of hygienic studies on the effect of chemical compounds on the reproductive function of animals].
    Shtenberg AI; Torchinskiĭ AM; Gavrilenko EV
    Vestn Akad Med Nauk SSSR; 1970; 25(12):65-72. PubMed ID: 5509561
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present position of the toxicology of drugs].
    Frohberg H
    Munch Med Wochenschr; 1970 Aug; 112(35):1532-43. PubMed ID: 4990080
    [No Abstract]   [Full Text] [Related]  

  • 11. Introduction to special issue on developmental and reproductive toxicology in China.
    Daston GP
    Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):1. PubMed ID: 20166228
    [No Abstract]   [Full Text] [Related]  

  • 12. Symposium: Mechanisms of Reproductive and Developmental Toxicology. April 1, 1986, Swedeland, PA. Proceedings.
    Environ Health Perspect; 1986 Dec; 70():85-191. PubMed ID: 3830116
    [No Abstract]   [Full Text] [Related]  

  • 13. Reproductive toxicity testing for pharmaceuticals under ICH.
    Barrow PC
    Reprod Toxicol; 2009 Sep; 28(2):172-9. PubMed ID: 19631153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in reproductive toxicology.
    Borzelleca JF
    Clin Lab Med; 1984 Sep; 4(3):461-7. PubMed ID: 6478764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teratogenic drug screening. Present procedures and requirements.
    Tuchmann-Duplessis H
    Teratology; 1972 Jun; 5(3):271-85. PubMed ID: 5067718
    [No Abstract]   [Full Text] [Related]  

  • 16. Animal toxicology studies on new medicines and their relationship to clinical exposure: a review of international recommendations.
    Scales MD; Mahoney K
    Adverse Drug React Toxicol Rev; 1991; 10(3):155-68. PubMed ID: 1747442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translational toxicology and the work of the predictive safety testing consortium.
    Mattes WB; Walker EG
    Clin Pharmacol Ther; 2009 Mar; 85(3):327-30. PubMed ID: 19158666
    [No Abstract]   [Full Text] [Related]  

  • 18. Reproductive toxicity risk assessment of chemicals.
    Rao KS; Schwetz BA; Park CN
    Vet Hum Toxicol; 1981 Jun; 23(3):167-75. PubMed ID: 7245602
    [No Abstract]   [Full Text] [Related]  

  • 19. [Necessity of a unified concept of adaptation].
    Shepelin OP
    Gig Tr Prof Zabol; 1988 Dec; (12):34-7. PubMed ID: 3248742
    [No Abstract]   [Full Text] [Related]  

  • 20. International Cooperation on Harmonisation of Technical requirements for Approval of Veterinary Medicinal Products (VICH); final guidance on " Safety studies for veterinary drug residues in human food: reproduction toxicity testing" (VICH GL22); availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(3):603-5. PubMed ID: 12365425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.